Sudarshan Pharma Industries Ltd strategy deck summary

Strategy deck of 18 Aug 2026, summarised by AI from the filing.

Sudarshan Pharma reported June 2026 revenue from operations of ₹174.41 cr and targets minimum ₹100 cr export turnover for FY 26-27.

Key takeaways

1. Export target Management targets minimum ₹100 cr export turnover for FY 26-27, after ₹21.85 cr in FY 25-26.
2. Certifications The Hyderabad facility was awarded GMP certification for API intermediates and active pharmaceutical ingredients, and ISO 9001:2015 for quality management.
3. China dependence High dependence on China for import of key APIs and intermediates exposes the company to supply disruptions and price rises.

Original filing on BSE

Sudarshan Pharma Industries Ltd earnings call, investor presentation and press release summaries

• Q4 FY25: Results deck (2 May 2025)
• Other events: Strategy deck (18 Aug 2026), Strategy deck (14 Aug 2026), Strategy deck (15 May 2026), Strategy deck (31 Jan 2026), Strategy deck (14 Aug 2025)